Results 21 to 30 of about 9,502,534 (376)
Orphanet Journal of Rare Diseases, 2021 Background With the approval of three treatments for spinal muscular atrophy (SMA) and several promising therapies on the horizon, the SMA adolescent and young adult populations are expected to evolve in the coming years.
Allison Mazzella +4 more
semanticscholar +1 more source
Трансплантология (Москва), 2020 We present an uncommon case of liver graft dysfunction caused by seronegative hepatitis C-related fibrosing cholestatic hepatitis after cadaver liver transplantation for unresectable liver metastases of neuroendocrine small intestine cancer followed by ...
S. E. Voskanyan +9 more
doaj +1 more source
eXPRESS Polymer Letters, 2018 Poly(trimethylene 2,5-furanoate) (PTF) nanocomposites reinforced with few layer graphene (FLG) were prepared through in situ polymerization. The method in question allows obtaining well-dispersed nanoplatelets in the whole volume of PTF matrix.
S. Paszkiewicz +8 more
doaj +1 more source
Gastric perforation and pancreatitis manifesting after an inadvertent nissen fundoplication in a patient with superior mesenteric artery syndrome. [PDF]
, 2009 Superior mesenteric artery (SMA) syndrome is an uncommon but well-recognized clinical entity. It can lead to proximal small bowel obstruction and severe morbidity and mortality in lieu of late diagnosis and concomitant existing comorbidities. We report a
Estrada, JJ +5 more
core +3 more sources
Bilateral segmentectomies using virtual-assisted lung mapping (VAL-MAP) for metastatic lung tumors
Surgical Case Reports, 2017 Background Virtual-assisted lung mapping (VAL-MAP) has been used not only in wedge resection but also in segmentectomy for hardly palpable lung nodules.
Keita Nakao +3 more
doaj +1 more source
Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy [PDF]
, 2016 Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein, primarily affecting lower motor neurons. Recent evidence from SMA and related conditions suggests that glial cells can influence disease severity.
Brophy, Peter J. +9 more
core +3 more sources
Journal of Neuromuscular Diseases, 2019 Objective: Spinal muscular atrophy (SMA) is a progressive autosomal recessive motor neuron disease caused by loss of the SMN1 gene. Based on randomized clinical trials in children with SMA type 1 and 2, Nusinersen has been approved as the first treatment
M. Walter +10 more
semanticscholar +1 more source
Communications in Development and Assembling of Textile Products, 2023 Developments in textile and fiber engineering have allowed the development of functional clothing such as protective wear, sportswear, and medical clothing.
Dominique Almendariz +2 more
doaj
Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening [PDF]
, 2018 Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by the degeneration of alpha motor neurons in the spinal cord, leading to muscular atrophy.
Connolly, Anne +14 more
core +2 more sources
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.
Journal of Clinical Investigation, 2019 BACKGROUNDSpinal muscular atrophy (SMA) is caused by deficient expression of survival motor neuron (SMN) protein. New SMN-enhancing therapeutics are associated with variable clinical benefits.
Daniel M. Ramos +21 more
semanticscholar +1 more source